ResMed Inc. (RSMDF)
OTCMKTS · Delayed Price · Currency is USD
24.34
-0.30 (-1.24%)
Nov 21, 2025, 4:00 PM EST
ResMed Revenue
ResMed had revenue of $1.34B in the quarter ending September 30, 2025, with 9.07% growth. This brings the company's revenue in the last twelve months to $5.26B, up 9.36% year-over-year. In the fiscal year ending June 30, 2025, ResMed had annual revenue of $5.15B with 9.84% growth.
Revenue (ttm)
5.26B
Revenue Growth
+9.36%
P/S Ratio
6.96
Revenue / Employee
495.98K
Employees
10,600
Market Cap
36.60B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 5.15B | 461.03M | 9.84% |
| Jun 30, 2024 | 4.69B | 462.30M | 10.95% |
| Jun 30, 2023 | 4.22B | 644.87M | 18.02% |
| Jun 30, 2022 | 3.58B | 381.30M | 11.93% |
| Jun 30, 2021 | 3.20B | 239.81M | 8.11% |
| Jun 30, 2020 | 2.96B | 350.44M | 13.44% |
| Jun 30, 2019 | 2.61B | 266.38M | 11.38% |
| Jun 30, 2018 | 2.34B | 273.46M | 13.23% |
| Jun 30, 2017 | 2.07B | 228.02M | 12.40% |
| Jun 30, 2016 | 1.84B | 159.80M | 9.52% |
| Jun 30, 2015 | 1.68B | 123.94M | 7.97% |
| Jun 30, 2014 | 1.55B | 40.52M | 2.68% |
| Jun 30, 2013 | 1.51B | 145.94M | 10.66% |
| Jun 30, 2012 | 1.37B | 125.37M | 10.08% |
| Jun 30, 2011 | 1.24B | 150.79M | 13.80% |
| Jun 30, 2010 | 1.09B | 171.62M | 18.64% |
| Jun 30, 2009 | 920.74M | 85.34M | 10.22% |
| Jun 30, 2008 | 835.40M | 119.07M | 16.62% |
| Jun 30, 2007 | 716.33M | 109.34M | 18.01% |
| Jun 30, 2006 | 607.00M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Global Cord Blood | 196.10M |
| Elite Pharmaceuticals | 122.89M |
| Mid-Atlantic Home Health Network | 27.00M |
| Silence Therapeutics | 25.83M |
| Tian'an Technology Group | 2.12M |
ResMed News
- 12 days ago - Could GLP-1 Drugs Make ResMed's CPAP Machines Obsolete? - The Motley Fool
- 13 days ago - Ex-Dividend Reminder: UNITIL, American Water Works and ResMed - Nasdaq
- 21 days ago - RMD: Baird Lowers Price Target for ResMed to $300 While Maintaining Outperform Rating | RMD ... - GuruFocus
- 24 days ago - RMD: RBC Capital Raises Price Target, Maintains Outperform Rating | RMD Stock News - GuruFocus
- 24 days ago - Keybanc Analyst Raises ResMed (RMD) Price Target to $299 | RMD Stock News - GuruFocus
- 24 days ago - Mizuho Maintains 'Outperform' for RMD but Lowers Price Target | RMD Stock News - GuruFocus
- 24 days ago - These Analysts Revise Their Forecasts On ResMed Following Q1 Results - Benzinga
- 24 days ago - These Analysts Revise Their Forecasts On ResMed Following Q1 Results - Benzinga